SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: JEB who wrote (184)1/8/1999 7:12:00 PM
From: QuietWon  Read Replies (3) | Respond to of 2515
 
IMCL has # prods in pipeline- u get cancer drugs,C225,etc and even get a stem-cell development. If any of these does well IMCL should do well - C225 in Phase III



To: JEB who wrote (184)1/8/1999 9:10:00 PM
From: CPAMarty  Respond to of 2515
 
I would not call myself an expert in theis stock or in technical analysis for that matter, but the selling volume on December 15 looks a little heavy for tax selling or even sell on the news

bigcharts.com

i think i will call IMCL next week and try to find out more details about this


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News